{"id":"2364","presentation":"RELATIONSHIP BETWEEN CSF ABETA42\/40 AND [18F]FLUTEMETAMOL PET-DERIVED CENTILOID UNITS IN SUBJECTIVE COGNITIVE DECLINE AND MILD COGNITIVE IMPAIRMENT <small>(ID 2364)<\/small>","session":"1710 - ONSITE SYMPOSIUM: AD, FTD, LBD DIAGNOSIS. EEG & CLINICAL TRIALS & ADVANCES IN DRUG DEVELOPMENT <small>(ID 257)<\/small>","filename":"ADPD Presentation - March 2022_for PDF Upload.pdf","speaker":"Mark Battle<small> (United Kingdom)<\/small>","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/adpd22\/persons\/photos\/2137.jpg","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/adpd22\/2364\/jpg\/adpdpresentation-march2022_forpdfupload\/thumbnails\/0.jpg","pdf":"\/file_access\/get_file\/E6986\/session_token\/e4394999bae323dac372ec0a5e3f1f39","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]